Research Topics
| Bengt FellstromSummaryAffiliation: Uppsala University Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Risk factors for and management of post-transplantation cardiovascular diseaseB Fellstrom
Department of Medical Sciences, University Hospital, SE 751 85 Uppsala, Sweden
BioDrugs 15:261-78. 2001....- Cardiovascular disease in patients with renal disease: the role of statinsBengt Fellstrom
Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
Curr Med Res Opin 25:271-85. 2009..This review describes available data relating to cardiovascular outcomes and the role of statins in patients with CKD, including pre-dialysis, dialysis, and renal transplant patients... - Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA studyBengt Fellstrom
Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
Kidney Blood Press Res 30:314-22. 2007..Cardiovascular disease (CVD) is the leading cause of death in patients with end-stage renal disease (ESRD)... - No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) studyBengt Fellstrom
Department of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden
Clin Transplant 20:732-9. 2006..This study investigated the effect of fluvastatin treatment on renal function in renal transplant recipients enrolled in the Assessment of Lescol in Renal Transplantation (ALERT) trial... - Cardioprotective role of statins in chronic kidney disease: do we have the answer?Bengt C Fellström
Department of Nephrology, Uppsala University, Uppsala, Sweden
Kidney Int 79:931-2. 2011..The results indicate that statins should be used more frequently after myocardial infarction in CKD classes lower than 5, a conclusion supported by the recently presented Study of Heart and Renal Protection (SHARP)... - Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantationB Fellstrom
University Hospital, Uppsala, Sweden
Am J Transplant 5:1986-91. 2005..In conclusion, elevated serum creatinine is a strong risk factor for all-cause, non-cardiovascular and cardiac mortality, and MACE, independent of traditional risk factors, but not for stroke or non-fatal MI alone... - Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trialBengt Fellstrom
University Hospital, Uppsala, Sweden
Transplantation 79:1160-3. 2005..We evaluated the effects of baseline renal-transplant function on mortality and cardiovascular and renal endpoints in 1,052 placebo-treated patients of the Assessment of Lescol in Renal Transplantation trial... - Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trialBengt Fellstrom
Department of Medical Science, Renal Science, Renal Unit, University Hospital, Uppsala, Sweden
Transplantation 79:205-12. 2005.... - Cyclosporine nephrotoxicityB Fellstrom
Department of Internal Medicine, Renal Unit, University Hospital, Uppsala, Sweden
Transplant Proc 36:220S-223S. 2004..These measures to deal with CSA toxicity need further documentation, since a preserved good renal function seems to not only have an important impact on graft survival but also on patient survival... - Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström
Department of Medical Science, Renal Unit, University Hospital, SE 751 85, Uppsala, Sweden
N Engl J Med 360:1395-407. 2009..Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been proved... - Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trialBengt Fellstrom
University Hospital, Uppsala, Sweden
Kidney Int 66:1549-55. 2004..The aim of the present study was to evaluate the effect of fluvastatin on long-term renal transplant function and development of chronic allograft nephropathy in the ALERT (Assessment of Lescol in Renal Transplantation) study... - Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortalityInga Soveri
Department of Medical Sciences, Uppsala University Hospital, entr 40, 75185, Uppsala, Sweden
Nephrol Dial Transplant 21:2282-9. 2006..The impact of renal dysfunction was compared with traditional risk factors for cardiovascular morbidity and mortality in 1052 placebo-treated patients of the ALERT trial... - Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatmentInga Soveri
Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Clin Transplant 23:914-20. 2009..Statin treatment reduces CVD risk in RTR. The aim was to study MS as CVD risk factor in RTR, and to investigate the effect of statin treatment in RTR with MS... - Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trialInga Soveri
Department of Medical Sciences, Uppsala University, Uppsala, Sweden
J Nephrol 25:245-54. 2012..We aimed to study MS as a risk factor for RGL. Also, the effect of statin treatment in reducing renal risk in renal transplant recipients (RTRs) with MS was studied... - A cardiovascular risk calculator for renal transplant recipientsInga Soveri
Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Transplantation 94:57-62. 2012..Standard CVD risk calculators are poorly predictive in RTRs; we therefore aimed to develop and validate an equation for CVD risk prediction in this population... - Improvement in central arterial pressure waveform during hemodialysis is related to a reduction in asymmetric dimethylarginine (ADMA) levelsInga Soveri
Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Nephron Clin Pract 106:c180-6. 2007..Therefore, we aimed to study changes in ADMA levels and central arterial pressure waveform during HD... - Erythropoietin impairs endothelial vasodilatory function in patients with renal anemia and in healthy subjectsMargus Annuk
Department of Medical Sciences, University Hospital, Uppsala, Sweden
Nephron Clin Pract 102:c30-4. 2006..The aim of the present study was to investigate the effects of epoetin alfa on endothelial vasodilatory function in patients with renal anemia and in healthy subjects... - Prevention of cardiovascular disease after renal transplantationMy Svensson
Department of Nephrology, Aarhus University Hospital, Aarhus, Denmark
Curr Opin Organ Transplant 17:393-400. 2012..Guidelines for prevention of CVD are mainly based on data from the general population. The purpose of this review is to give a practical approach on prevention of CVD in renal transplant recipients... - New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuriaHilde Kloster Smerud
Department of Medical Sciences, Division of Nephrology, Uppsala University Hospital, University of Uppsala, Uppsala, Sweden
Nephrol Dial Transplant 26:3237-42. 2011..The primary objective was to evaluate the efficacy of targeted release budesonide on albuminuria... - Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purificationNatalia Ferraz
Nanotechnology and Functional Materials, Department of Engineering Sciences, Uppsala University, The Angstrom Laboratory, Box 534, 75121 Uppsala, Sweden
J R Soc Interface 9:1943-55. 2012..The heparinized PPy-cellulose composite is consequently a promising haemodialysis material, with respect to both potential-controlled extraction of small uraemic toxins and haemocompatibility... - Cyclooxygenase inhibition improves endothelium-dependent vasodilatation in patients with chronic renal failureMargus Annuk
Department of Medical Science, University Hospital, Uppsala, Sweden
Nephrol Dial Transplant 17:2159-63. 2002..The aim of the present study was to investigate the acute effects of L-arginine and diclofenac on endothelium-dependent vasodilatation (EDV) and endothelium-independent vasodilatation (EIDV) in patients with chronic renal failure (CRF)... - Serum levels of antibodies against oxidised LDL in kidney graft recipientsLelija Zezina
Department of Medical Sciences, Uppsala University, Uppsala, Sweden
Am J Nephrol 22:539-47. 2002....